Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bifunctional epoxide hydrolase 2 | ||
Ligand | BDBM50335973 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_716998 (CHEMBL1671070) | ||
IC50 | 270±n/a nM | ||
Citation | Anandan, SK; Webb, HK; Chen, D; Wang, YX; Aavula, BR; Cases, S; Cheng, Y; Do, ZN; Mehra, U; Tran, V; Vincelette, J; Waszczuk, J; White, K; Wong, KR; Zhang, LN; Jones, PD; Hammock, BD; Patel, DV; Whitcomb, R; MacIntyre, DE; Sabry, J; Gless, R 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia. Bioorg Med Chem Lett21:983-8 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Bifunctional epoxide hydrolase 2 | |||
Name: | Bifunctional epoxide hydrolase 2 | ||
Synonyms: | Cytosolic epoxide hydrolase 2 | EBifunctional epoxide hydrolase 2 | EPHX2 | Epoxide hydratase | HYES_HUMAN | Lipid-phosphate phosphatase | Soluble epoxide hydrolase (sEH) | epoxide hydrolase 2, cytoplasmic | ||
Type: | Enzyme | ||
Mol. Mass.: | 62613.07 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P34913 | ||
Residue: | 555 | ||
Sequence: |
| ||
BDBM50335973 | |||
n/a | |||
Name | BDBM50335973 | ||
Synonyms: | 1-(1-acetylpiperidin-4-yl)-3-(4-tert-butylcyclohexyl)urea | CHEMBL1668929 | ||
Type | Small organic molecule | ||
Emp. Form. | C18H33N3O2 | ||
Mol. Mass. | 323.4735 | ||
SMILES | CC(=O)N1CCC(CC1)NC(=O)NC1CCC(CC1)C(C)(C)C |(1.63,-5.6,;1.57,-7.14,;.21,-7.87,;2.88,-7.96,;4.25,-7.24,;5.55,-8.05,;5.49,-9.6,;4.14,-10.32,;2.83,-9.51,;6.8,-10.41,;6.75,-11.95,;5.39,-12.68,;8.07,-12.76,;8.05,-14.31,;6.71,-15.06,;6.69,-16.59,;8.02,-17.38,;9.36,-16.62,;9.38,-15.08,;8,-18.92,;6.66,-19.67,;9.32,-19.7,;7.98,-20.45,)| | ||
Structure |